1	En	en	SPS00	C1720294#C0332285	calificador#atributo	0-2	760(2)_ANS_clinical_caseMIR	SENT1	-	-
2	presencia	presenciar	VMM02S0	C0150312_1	calificador_1	3-12	760(2)_ANS_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0150312_2	calificador_2	13-15	760(2)_ANS_clinical_caseMIR	SENT1	-	-
4	clínica	clínico	AQ0FS0	C0205210	calificador	16-23	760(2)_ANS_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
5	isquémica	isquémico	AQ0FS0	C0475224	calificador	24-33	760(2)_ANS_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
6	,	,	Fc	-	-	33-34	760(2)_ANS_clinical_caseMIR	SENT1	-	-
7	y	y	CC	C1706368	calificador	35-36	760(2)_ANS_clinical_caseMIR	SENT1	-	-
8	para	para	SPS00	C0521125	calificador	37-41	760(2)_ANS_clinical_caseMIR	SENT1	-	-
9	no	no	RN	C1298908	calificador	42-44	760(2)_ANS_clinical_caseMIR	SENT1	-	-
10	empeorar	empeorar	VMN0000	-	-	45-53	760(2)_ANS_clinical_caseMIR	SENT1	-	-
11	el	el	DA0MS0	-	-	54-56	760(2)_ANS_clinical_caseMIR	SENT1	-	-
12	riesgo	riesgo	NCMS000	-	-	57-63	760(2)_ANS_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
13	vascular	vascular	AQ0CS0	-	-	64-72	760(2)_ANS_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
14	del	del	SP+DA	-	-	73-76	760(2)_ANS_clinical_caseMIR	SENT1	-	-
15	paciente	paciente	NCCS000	C0030705	persona	77-85	760(2)_ANS_clinical_caseMIR	SENT1	-	-
16	,	,	Fc	-	-	85-86	760(2)_ANS_clinical_caseMIR	SENT1	-	-
17	se	se	P00CN000	-	-	87-89	760(2)_ANS_clinical_caseMIR	SENT1	-	-
18	debe	deber	VMIP3S0	-	-	90-94	760(2)_ANS_clinical_caseMIR	SENT1	-	-
19	evitar	evitar	VMN0000	-	-	95-101	760(2)_ANS_clinical_caseMIR	SENT1	-	-
20	el	el	DA0MS0	-	-	102-104	760(2)_ANS_clinical_caseMIR	SENT1	-	-
21	uso	uso	NCMS000	C0457083#C1947944	atributo#calificador	105-108	760(2)_ANS_clinical_caseMIR	SENT1	-	-
22	de	de	SPS00	C0332285	atributo	109-111	760(2)_ANS_clinical_caseMIR	SENT1	-	-
23	glucocorticoides	glucocorticoide	NCMP000	C0017710	producto#sustancia	112-128	760(2)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
24	a	a	SPS00	-	-	129-130	760(2)_ANS_clinical_caseMIR	SENT1	-	-
25	dosis	dosis	NCFN000	-	-	131-136	760(2)_ANS_clinical_caseMIR	SENT1	-	-
26	superiores	superior	AQ0CP0	C1282910	calificador	137-147	760(2)_ANS_clinical_caseMIR	SENT1	-	-
27	a	a	SPS00	-	-	148-149	760(2)_ANS_clinical_caseMIR	SENT1	-	-
28	30	30	Z	-	-	150-152	760(2)_ANS_clinical_caseMIR	SENT1	-	-
29	mg	mg	NCMN000	-	-	153-155	760(2)_ANS_clinical_caseMIR	SENT1	-	-
30	/	/	Fh	-	-	155-156	760(2)_ANS_clinical_caseMIR	SENT1	-	-
31	día	día	NCMS000	C0439228#C0332169	calificador	156-159	760(2)_ANS_clinical_caseMIR	SENT1	-	-
32	.	.	Fp	-	-	159-160	760(2)_ANS_clinical_caseMIR	SENT1	-	-

